• 1
    Avraham T, Yan A, Zampell JC, et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol. 2010; 299: C589-605.
  • 2
    Malicka I, Stefanska M, Pawlowska K, Wozniewski M. Function of muscles of flexors and extensors of the elbow joint in women after treatment of breast cancer. Ortop Traumatol Rehabil. 2009; 11: 111-119.
  • 3
    Westrup JL, Lash TL, Thwin SS, Silliman RA. Risk of decline in upper-body function and symptoms among older breast cancer patients. J Gen Intern Med. 2006; 21: 327-333.
  • 4
    Taira N, Shimozuma K, Shiroiwa T, et al. Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery. Breast Cancer Res Treat. 2011; 128: 735-747.
  • 5
    Deutsch M, Flickinger JC. Shoulder and arm problems after radiotherapy for primary breast cancer. Am J Clin Oncol. 2001; 24: 172-176.
  • 6
    Hack TF, Kwan WB, Thomas-Maclean RL, et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology. 2010; 19: 1205-1212.
  • 7
    Shamley DR, Srinanaganathan R, Weatherall R, et al. Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat. 2007; 106; 19-27.
  • 8
    Albert US, Koller M, Kopp I, Lorenz W, Schulz KD, Wagner U. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat. 2006; 100: 285-292.
  • 9
    Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011; 50: 187-193.
  • 10
    Cheville AL. Cancer rehabilitation. Semin Oncol. 2005; 32: 219-224.
  • 11
    Devoogdt N, Van Kampen M, Christiaens MR, et al. Short- and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care (Engl). 2011; 20: 77-86.
  • 12
    Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B. Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes. 2010; 8: 92.
  • 13
    Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008; 26: 3536-3542.
  • 14
    Gerber LH, Stout N, McGarvey C, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2011; 19: 1581-1591.
  • 15
    Smoot B, Wong J, Cooper B, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010; 4: 167-178.
  • 16
    Nesvold IL, Dahl AA, Lokkevik E, Marit Mengshoel A, Fossa SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008; 47: 835-842.
  • 17
    Helms G, Kuhn T, Moser L, Remmel E, Kreienberg R. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection—data from a prospective randomised trial. Eur J Surg Oncol. 2009; 35: 696-701.
  • 18
    Augusto C, Pietro M, Cinzia M, et al. Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings. J Neurooncol. 2007; 86: 89-99.
  • 19
    Paim CR, de Paula Lima ED, Fu MR, de Paula Lima A, Cassali GD. Postlymphadenectomy complications and quality of life among breast cancer patients in Brazil. Cancer Nurs. 2008; 31: 302-309; quiz 10-11.
  • 20
    Perez EA, Weilbaecher K. Aromatase inhibitors and bone loss. Oncology (Williston Park). 2006; 20: 1029-1039; discussion 39-40, 42, 48.
  • 21
    Michaud LB, Goodin S. Cancer-treatment-induced bone loss, part 2. Am J Health Syst Pharm. 2006; 63: 534-546.
  • 22
    Rietman J, Dijkstra P, Debreczeni R, Geertzen J, Robinson D, De Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004; 26: 78-84.
  • 23
    Bennett B, Goldstein D, Lloyd A, Davenport T, Hickie I. Fatigue and psychological distress—exploring the relationship in women treated for breast cancer. Eur J Cancer. 2004; 40: 1689-1695.
  • 24
    Leidenius M, Leppanen E, Krogerus L, von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg. 2003; 185: 127-130.
  • 25
    Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2005: 1-15.
  • 26
    Hirbe A, Morgan EA, Uluckan O, Weilbaecher K. Skeletal complications of breast cancer therapies. Clin Cancer Res. 2006; 12( Pt 2): 6309s-6314s.
  • 27
    Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology. 2006; 15: 921-930.
  • 28
    Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment—a nationwide study of prevalence and associated factors. Breast. 2010; 19: 506-515.
  • 29
    Visovsky C. Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther. 2006; 5: 183-191.
  • 30
    Braithwaite D, Satariano WA, Sternfeld B, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010; 102: 1468-1477.
  • 31
    Treish I, Schwartz R, Lindley C. Pharmacology and therapeutic use of trastuzumab in breast cancer. Am J Health Syst Pharm. 2000; 57: 2063-2076; quiz 77-79.
  • 32
    Boehmke MM, Dickerson SS. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs. 2005; 28: 382-389.
  • 33
    Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997; 35: 47-53.
  • 34
    Chachaj A, Malyszczak K, Pyszel K, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology. 2010; 19: 299-305.
  • 35
    Nesvold IL, Fossa SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol. 2010; 49: 347-353.
  • 36
    Bosompra K, Ashikaga T, O'Brien PJ, Nelson L, Skelly J. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J. 2002; 8: 338-348.
  • 37
    Tahan G, Johnson R, Mager L, Soran A. The role of occupational upper extremity use in breast cancer related upper extremity lymphedema. J Cancer Surviv. 2010; 4: 15-19.
  • 38
    Karki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005; 37: 180-188.
  • 39
    Hayes SC, Battistutta D, Parker AW, Hirst C, Newman B. Assessing task “burden” of daily activities requiring upper body function among women following breast cancer treatment. Support Care Cancer. 2005; 13: 255-265.
  • 40
    Levangie PK, Santasier AM, Stout NL, Pfalzer L. A qualitative assessment of upper quarter dysfunction reported by physical therapists treated for breast cancer or treating breast cancer sequelae. Support Care Cancer. 2011; 19: 1367-1378.
  • 41
    Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003; 79: 47-57.
  • 42
    Deshpande AD, Sefko JA, Jeffe DB, Schootman M. The association between chronic disease burden and quality of life among breast cancer survivors in Missouri. Breast Cancer Res Treat. 2011; 129: 877-886.
  • 43
    Kjaer TK, Johansen C, Ibfelt E, et al. Impact of symptom burden on health related quality of life of cancer survivors in a Danish cancer rehabilitation program: a longitudinal study. Acta Oncol. 2011; 50: 223-232.
  • 44
    Schmitz KH, Speck RM, Rye SA, DiSipio T, Hayes SC. Prevalence of breast cancer treatment sequelae over 6 years of follow up: The Pulling Through Study. Cancer. 2012; 118( suppl 8): 2217-2225.
  • 45
    Cheville AL, Beck LA, Petersen TL, Marks RS, Gamble GL. The detection and treatment of cancer-related functional problems in an outpatient setting. Support Care Cancer. 2009; 17: 61-67.
  • 46
    Bland KL, Perczyk R, Du W, et al. Can a practicing surgeon detect early lymphedema reliably? Am J Surg. 2003; 186: 509-513.
  • 47
    Hewitt M, Greenfield S, Stovall E. Cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2005.
  • 48
    Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008; 26: 759-767.
  • 49
    Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002; 75: 51-64.
  • 50
    Cinar N, Seckin U, Keskin D, Bodur H, Bozkurt B, Cengiz O. The effectiveness of early rehabilitation in patients with modified radical mastectomy. Cancer Nurs. 2008; 31: 160-165.
  • 51
    de Rezende LF, Franco RL, de Rezende MF, Beletti PO, Morais SS, Gurgel MS. Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance. Tumori. 2006; 92: 55-61.
  • 52
    Fialka-Moser V, Crevenna R, Korpan M, Quittan M. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003; 35: 153-162.
  • 53
    McAnaw MB, Harris KW. The role of physical therapy in the rehabilitation of patients with mastectomy and breast reconstruction. Breast Dis. 2002; 16: 163-174.
  • 54
    McNeely ML, Campbell K, Ospina M, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev. 2010; 6: CD005211.
  • 55
    McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006; 175: 34-41.
  • 56
    Lee SA, Kang JY, Kim YD, et al. Effects of a scapula-oriented shoulder exercise programme on upper limb dysfunction in breast cancer survivors: a randomized controlled pilot trial. Clin Rehabil. 2010; 24: 600-613.
  • 57
    Wonders KY, Reigle BS. Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise. Integr Cancer Ther. 2009; 8: 17-21.
  • 58
    Schwartz AL, Winters-Stone K, Gallucci B. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 2007; 34: 627-633.
  • 59
    Turner J, Hayes S, Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol. 2004; 86: 141-146.
  • 60
    Gomide LB, Matheus JP, Candido Dos Reis FJ. Morbidity after breast cancer treatment and physiotherapeutic performance. Int J Clin Pract. 2007; 61: 972-982.
  • 61
    Gerber LH, Stout NL, Schmitz KH, Stricker CT. Integrating a prospective model of surveillance for physical impairments into breast cancer survivorship care. Cancer. 2012; 118( suppl 8): 2201-2206.
  • 62
    Binkley JM, Harris SR, Levangie PK, et al. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 2012; 118( suppl 8): 2207-2216.
  • 63
    McNeely ML, Binkley JM, Pusic AL, Campbell KL, Gabram S, Soballe PW. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues. Cancer. 2012; 118( suppl 8): 2226-2236.
  • 64
    Hayes SC, Johansson K, Stout NL, et al. Upper-body morbidity following breast cancer: incidence and evidence for evaluation, prevention and management within a prospective surveillance model of rehabilitation. Cancer. 2012; 118( suppl 8): 2217-2225.
  • 65
    Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy induced neuropathy. Cancer. 2012; 118( suppl 8): 2250-2260.
  • 66
    Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012; 118( suppl 8): 2261-2269.
  • 67
    Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR. Prospective surveillance and management of cardiovascular health in breast cancer survivors. Cancer. 2012; 118( suppl 8): 2270-2276.
  • 68
    Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012;118 lpar;suppl 8): 2277-2287.
  • 69
    Winters-Stone KM, Schwartz AL, Hayes SC, Fabian CJ, Campbell KL. A prospective model of care for breast cancer rehabilitation: bone health and arthralgia. Cancer. 2012; 118( suppl 8): 2288-2299.
  • 70
    Campbell KL, Pusic AL, Zucker DS, et al. A prospective model of care for breast cancer rehabilitation: function. Cancer. 2012; 118( suppl 8): 2300-2311.
  • 71
    Harris SR, Schmitz KH, Campbell KL, McNeely ML. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer. 2012; 118( suppl 8): 2312-2324.
  • 72
    Cheville AL, Nyman JA, Pruthi S, Basford JR. Cost considerations regarding the prospective surveillance model for breast cancer survivors. Cancer. 2012; 118( suppl 8): 2325-2330.
  • 73
    Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008; 112: 2809-2819.
  • 74
    Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010; 43: 118-127.
  • 75
    Springer BA, Levy E, McGarvey C, et al. Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat. 2010; 120: 135-147.
  • 76
    Yang EJ, Park WB, Seo KS, Kim SW, Heo CY, Lim JY. Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol. 2010; 101: 84-91.
  • 77
    Stout NL. Cancer prevention in physical therapist practice. Phys Ther. 2009; 89( 11): 1119-1122.
  • 78
    Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008; 112: 2809-2819.
  • 79
    Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010; 340: b5396.
  • 80
    Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res Treat. 2002; 75: 35-50.
  • 81
    Midtgaard J, Tveteras A, Rorth M, Stelter R, Adamsen L. The impact of supervised exercise intervention on short-term postprogram leisure time physical activity level in cancer patients undergoing chemotherapy: 1- and 3-month follow-up on the body & cancer project. Palliat Support Care. 2006; 4: 25-35.
  • 82
    Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2008; 108: 279-288.
  • 83
    Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996; 74: 511-544.
  • 84
    Cheville AL, Troxel AB, Basford JR, Kornblith AB. Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol. 2008; 26: 2621-2629.
  • 85
    Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM. Patient perceptions of arm care and exercise advice after breast cancer surgery. Oncol Nurs Forum. 2010; 37: 85-91.
  • 86
    Fu MR, Chen CM, Haber J, Guth AA, Axelrod D. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann Surg Oncol. 2010; 17: 1847-1853.
  • 87
    Windsor PM, Potter J, McAdam K, McCowan C. Evaluation of a fatigue initiative: information on exercise for patients receiving cancer treatment. Clin Oncol (R Coll Radiol). 2009; 21: 473-482.
  • 88
    Beaver K, Twomey M, Witham G, Foy S, Luker KA. Meeting the information needs of women with breast cancer: piloting a nurse-led intervention. Eur J Oncol Nurs. 2006; 10: 378-390.
  • 89
    Chan DN, Lui LY, So WK. Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review. J Adv Nurs. 2010; 66: 1902-1914.
  • 90
    Favarao KU, Mantese JC, Barros AC. Shoulder mobility after axillary sentinel node biopsy for early infiltrating breast cancer treatment. Eur J Gynaecol Oncol. 2010; 31: 23-26.
  • 91
    Todd J, Scally A, Dodwell D, Horgan K, Topping A. A randomised controlled trial of two programmes of shoulder exercise following axillary node dissection for invasive breast cancer. Physiotherapy. 2008; 94: 265-273.
  • 92
    Box R. Restriction of the range of arm elevation exercises for one week after surgery for breast cancer can reduce the incidence of lymphoedema. Aust J Physiother. 2009; 55: 64.
  • 93
    Blanchard CM, Courneya KS, Rodgers WM, Murnaghan DM. Determinants of exercise intention and behavior in survivors of breast and prostate cancer: an application of the theory of planned behavior. Cancer Nurs. 2002; 25: 88-95.
  • 94
    Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010; 42: 1409-1426.
  • 95
    MacMillan Cancer Support. The importance of physical activity for people living with and beyond cancer: a concise evidence review. London: MacMillan Cancer Support; 2011: 1-15.
  • 96
    Luctkar-Flude M, Groll D, Woodend K, Tranmer J. Fatigue and physical activity in older patients with cancer: a six-month follow-up study. Oncol Nurs Forum. 2009; 36: 194-202.
  • 97
    Ng A, Constine LS, Advani R, et al. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer. 2010; 34: 211-227.
  • 98
    Partsch H. Intermittent pneumatic compression in immobile patients. Int Wound J. 2008; 5: 389-397.
  • 99
    McBride D. ACSM releases new guidelines for physical activity for patients with cancer. ONS Connect. 2010; 25: 16.
  • 100
    Lattanzi JB, Giuliano S, Meehan C, Sander B, Wootten R, Zimmerman A. Recommendations for physical and occupational therapy practice from the perspective of clients undergoing therapy for breast cancer-related impairments. J Allied Health. 2010; 39: 257-264.
  • 101
    Larsson IL, Jonsson C, Olsson AC, Gard G, Johansson K. Women's experience of physical activity following breast cancer treatment. Scand J Caring Sci. 2008; 22: 422-429.
  • 102
    Hennessy EM, Stevinson C, Fox KR. Preliminary study of the lived experience of exercise for cancer survivors. Eur J Oncol Nurs. 2005; 9: 155-166.
  • 103
    Jones LW, Courneya KS, Fairey AS, Mackey JR. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med. 2004; 28: 105-113.
  • 104
    Armer JM, Heckathorn PW. Post-breast cancer lymphedema in aging women: self-management and implications for nursing. J Gerontol Nurs. 2005; 31: 29-39.
  • 105
    Bartsch HH, Weis J, Moser MT. Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors. Onkologie. 2003; 26: 51-57.
  • 106
    Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat. 2008; 110: 19-37.
  • 107
    Bajrovic A, Rades D, Fehlauer F, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol. 2004; 71: 297-301.
  • 108
    Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol. 2010; 49: 166-173.
  • 109
    Bar Ad V, Cheville A, Solin LJ, Dutta P, Both S, Harris EE. Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2010; 76: 85-90.
  • 110
    Ogce F, Ozkan S. Changes in functional status and physical and psychological symptoms in women receiving chemotherapy for breast cancer. Asian Pac J Cancer Prev. 2008; 9: 449-452.
  • 111
    Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol. 2008; 26: 2198-2204.
  • 112
    Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA. 2010; 304: 2699-2705.
  • 113
    Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology. 2009; 42: 1-9.
  • 114
    Springer BA, Levy E, McGarvey C, et al. Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat. 2010; 120: 135-147.
  • 115
    Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006; 24: 5117-5124.
  • 116
    Gosselink R, Rouffaer L, Vanhelden P, Piot W, Troosters T, Christiaens MR. Recovery of upper limb function after axillary dissection. J Surg Oncol. 2003; 83: 204-211.
  • 117
    Kitamura Y, Ohno Y, Kasahara S, et al. Statistical estimation of the number of breast cancer patients with disabilities resulting from surgery. Breast Cancer. 2005; 12: 130-134.
  • 118
    Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008; 24: 208-217.
  • 119
    Stout NL, Andrews K, Binkley JM, Schmitz KH, Smith RA. Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment. Cancer. 2012; 118( suppl 8): 2331-2334.